Pharmac funds second SMA therapy

By Megan Brodie 11 months ago | In New Zealand, Reimbursement
  • 11 months ago

12 April 2023 New Zealand’s Pharmac has swiftly followed the funding of Biogen’s first-in-class therapy…

This is subscriber-only content. Please login to continue reading.